Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies

Mortality in Patients with HIV-1 Infection Starting Antiretroviral Therapy in South Africa, Europe, or North America: A Collaborative Analysis of Prospective Studies

Andrew Boulle;Michael Schomaker;Margaret T. May;Robert S. Hogg;Bryan E. Shepherd;Susana Monge;Olivia Keiser;Fiona C. Lampe;Janet Giddy;James Ndirangu;Daniela Garone;Matthew Fox;Suzanne M. Ingle;Peter Reiss;Francois Dabis;Dominique Costagliola;Antonella Castagna;Kathrin Ehren;Colin Campbell;M. John Gill;Michael Saag;Amy C. Justice;Jodie Guest;Heidi M. Crane;Matthias Egger;Jonathan A. C. Sterne;
plos medicine 2014 Vol. 11 pp. e1001718-
328
boulle2014plosmortality

Abstract

Analyzing survival in HIV treatment cohorts, Andrew Boulle and colleagues find mortality rates in South Africa comparable to or better than those in North America by 4 years after starting antiretroviral therapy. Please see later in the article for the Editors' Summary

Citation

ID: 114252
Ref Key: boulle2014plosmortality
Use this key to autocite in SciMatic or Thesis Manager

References

Blockchain Verification

Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
114252
Unique Identifier:
10.1371/journal.pmed.1001718
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
5/5
Creates 1,000,000 NFT tokens for this article
Token Features:
  • ERC-1155 Standard NFT
  • 1 Million Supply per Article
  • Transferable via MetaMask
  • Permanent Blockchain Record
Blockchain QR Code
Scan with Saymatik Web3.0 Wallet

Saymatik Web3.0 Wallet